上皮癌-话题@MedSci

#上皮癌#

151篇内容 | 3336人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1539305, encodeId=8b201539305f1, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。, objectType=article, longId=118987, objectId=f6e211898e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e211898e5f, replyNumber=0, likeNumber=64, createdTime=2017-11-08, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e211898e5f, moduleTitle=Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e211898e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539304, encodeId=0ee915393043d, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Oncogene：ANGPTL4在泌尿上皮癌中的双重角色。, objectType=article, longId=116864, objectId=7e7711686465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e7711686465, replyNumber=0, likeNumber=74, createdTime=2017-10-21, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e7711686465, moduleTitle=Oncogene：ANGPTL4在泌尿上皮癌中的双重角色。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e7711686465)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539303, encodeId=4bff153930356, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=J Exp Med：靶向FSTL1-DIAPH1或可有效治疗上皮癌, objectType=article, longId=115424, objectId=aa00115424d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa00115424d0, replyNumber=0, likeNumber=59, createdTime=2017-10-10, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa00115424d0, moduleTitle=J Exp Med：靶向FSTL1-DIAPH1或可有效治疗上皮癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa00115424d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539302, encodeId=5ccc153930265, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Oncol Lett：膀胱尿路上皮癌的独立预后miRNAs, objectType=article, longId=114892, objectId=20db11489296, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20db11489296, replyNumber=0, likeNumber=62, createdTime=2017-10-01, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20db11489296, moduleTitle=Oncol Lett：膀胱尿路上皮癌的独立预后miRNAs, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20db11489296)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539301, encodeId=f411153930174, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Eur Urol：转移性尿路上皮癌，先免疫治疗 or 先化疗？, objectType=article, longId=113192, objectId=6cff11319268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cff11319268, replyNumber=0, likeNumber=90, createdTime=2017-09-20, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cff11319268, moduleTitle=Eur Urol：转移性尿路上皮癌，先免疫治疗 or 先化疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cff11319268)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539300, encodeId=b70315393001b, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Sci Rep：PD-L1、E-cadherin、CD24和VEGFR2是上皮癌干细胞的标记并且与快速肿瘤发生相关, objectType=article, longId=112313, objectId=3530112313d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3530112313d7, replyNumber=0, likeNumber=77, createdTime=2017-09-09, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3530112313d7, moduleTitle=Sci Rep：PD-L1、E-cadherin、CD24和VEGFR2是上皮癌干细胞的标记并且与快速肿瘤发生相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3530112313d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539299, encodeId=25831539299d7, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Int J Cancer：抗抑郁药或能降低卵巢上皮癌的风险, objectType=article, longId=111601, objectId=866f1116015a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=866f1116015a, replyNumber=0, likeNumber=77, createdTime=2017-09-02, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=866f1116015a, moduleTitle=Int J Cancer：抗抑郁药或能降低卵巢上皮癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=866f1116015a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539298, encodeId=53b21539298e8, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=JAMA Oncol： Durvalumab在局部晚期或转移性尿路上皮癌中疗效如何？, objectType=article, longId=110698, objectId=81a911069830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81a911069830, replyNumber=0, likeNumber=82, createdTime=2017-08-25, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81a911069830, moduleTitle=JAMA Oncol： Durvalumab在局部晚期或转移性尿路上皮癌中疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81a911069830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539297, encodeId=6ac8153929ea2, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Urol Oncol：上尿路上皮癌的优化治疗, objectType=article, longId=108586, objectId=494f10858658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=494f10858658, replyNumber=0, likeNumber=82, createdTime=2017-08-13, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=494f10858658, moduleTitle=Urol Oncol：上尿路上皮癌的优化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=494f10858658)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539296, encodeId=b9b715392965b, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Oncotarget：抑制PC-PLC活性在原癌基因HER2相关的卵巢上皮癌中表现出治疗作用, objectType=article, longId=105969, objectId=933d10596999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=933d10596999, replyNumber=0, likeNumber=28, createdTime=2017-07-20, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=933d10596999, moduleTitle=Oncotarget：抑制PC-PLC活性在原癌基因HER2相关的卵巢上皮癌中表现出治疗作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=933d10596999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539295, encodeId=609d1539295ee, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=PDL-1和CTLA-4招募晚期尿路上皮癌患者, objectType=article, longId=102247, objectId=8ed610224e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ed610224e25, replyNumber=0, likeNumber=78, createdTime=2017-06-18, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ed610224e25, moduleTitle=PDL-1和CTLA-4招募晚期尿路上皮癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ed610224e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539294, encodeId=a4451539294f9, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=SCI REP：ANLN有希望成为鉴定膀胱尿路上皮癌的预后生物标志物, objectType=article, longId=101414, objectId=3d3a101414c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d3a101414c7, replyNumber=0, likeNumber=75, createdTime=2017-06-11, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d3a101414c7, moduleTitle=SCI REP：ANLN有希望成为鉴定膀胱尿路上皮癌的预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d3a101414c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539293, encodeId=ea5715392930d, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Brit J Cancer：低密度脂蛋白胆固醇能够抵消酪氨酸激酶抑制剂对肾细胞上皮癌的抗肿瘤活性, objectType=article, longId=95153, objectId=4bce95153da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bce95153da, replyNumber=0, likeNumber=63, createdTime=2017-04-07, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bce95153da, moduleTitle=Brit J Cancer：低密度脂蛋白胆固醇能够抵消酪氨酸激酶抑制剂对肾细胞上皮癌的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bce95153da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539292, encodeId=0d391539292b0, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Lancet Oncology：长春氟宁用于晚期尿路上皮癌的维持治疗, objectType=article, longId=94694, objectId=413094694c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=413094694c0, replyNumber=0, likeNumber=83, createdTime=2017-04-06, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=413094694c0, moduleTitle=Lancet Oncology：长春氟宁用于晚期尿路上皮癌的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=413094694c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539291, encodeId=d8d7153929180, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Cancer：尿液样本的下一代测序：卡介苗治疗非肌肉侵入尿路上皮癌患者的基因组分析新平台！, objectType=article, longId=93619, objectId=895e9361936, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=895e9361936, replyNumber=0, likeNumber=57, createdTime=2017-03-29, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=895e9361936, moduleTitle=Cancer：尿液样本的下一代测序：卡介苗治疗非肌肉侵入尿路上皮癌患者的基因组分析新平台！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=895e9361936)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539290, encodeId=e3a91539290bd, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=NEJM：Pembrolizumab二线治疗尿路上皮癌优于化疗（KEYNOTE-045）, objectType=article, longId=92485, objectId=2590924851f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2590924851f, replyNumber=0, likeNumber=64, createdTime=2017-03-21, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2590924851f, moduleTitle=NEJM：Pembrolizumab二线治疗尿路上皮癌优于化疗（KEYNOTE-045）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2590924851f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539289, encodeId=2432153928996, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=NEJM：Pembrolizumab作为晚期尿路上皮癌二线治疗疗效如何？, objectType=article, longId=89310, objectId=b04a893104a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b04a893104a, replyNumber=0, likeNumber=0, createdTime=2017-02-20, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b04a893104a, moduleTitle=NEJM：Pembrolizumab作为晚期尿路上皮癌二线治疗疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b04a893104a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539288, encodeId=3b221539288b7, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=重磅！美国FDA批准百时美PD-1免疫疗法Opdivo治疗晚期尿路上皮癌（mUC）（CheckMate-275）, objectType=article, longId=88389, objectId=549e88389de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=549e88389de, replyNumber=0, likeNumber=81, createdTime=2017-02-08, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=549e88389de, moduleTitle=重磅！美国FDA批准百时美PD-1免疫疗法Opdivo治疗晚期尿路上皮癌（mUC）（CheckMate-275）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=549e88389de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539287, encodeId=2e69153928e47, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=lancet oncol：派姆单抗（pembrolizumab）在局部晚期或转移性尿路上皮癌患者中安全性和活性的1期临床研究(KEYNOTE-012), objectType=article, longId=87698, objectId=f06c8e69880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f06c8e69880, replyNumber=0, likeNumber=26, createdTime=2017-01-19, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f06c8e69880, moduleTitle=lancet oncol：派姆单抗（pembrolizumab）在局部晚期或转移性尿路上皮癌患者中安全性和活性的1期临床研究(KEYNOTE-012), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f06c8e69880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539286, encodeId=50d615392867a, content=<a href='/topic/show?id=0e802002e45' target=_blank style='color:#2F92EE;'>#上皮癌#</a>, objectTitle=Lancet：Atezolizumab可作为晚期尿路上皮癌顺铂的替代治疗, objectType=article, longId=83782, objectId=f08b83e82fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f08b83e82fc, replyNumber=0, likeNumber=50, createdTime=2016-12-09, rootId=0, userName=mashirong, userId=866a13134648, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f08b83e82fc, moduleTitle=Lancet：Atezolizumab可作为晚期尿路上皮癌顺铂的替代治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f08b83e82fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

上皮癌

2020-05-29

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。

2017-11-08

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Oncogene：ANGPTL4在泌尿上皮癌中的双重角色。

2017-10-21

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

J Exp Med：靶向FSTL1-DIAPH1或可有效治疗上皮癌

2017-10-10

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Oncol Lett：膀胱尿路上皮癌的独立预后miRNAs

2017-10-01

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Eur Urol：转移性尿路上皮癌，先免疫治疗 or 先化疗？

2017-09-20

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Sci Rep：PD-L1、E-cadherin、CD24和VEGFR2是上皮癌干细胞的标记并且与快速肿瘤发生相关

2017-09-09

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Int J Cancer：抗抑郁药或能降低卵巢上皮癌的风险

2017-09-02

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

JAMA Oncol： Durvalumab在局部晚期或转移性尿路上皮癌中疗效如何？

2017-08-25

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Urol Oncol：上尿路上皮癌的优化治疗

2017-08-13

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Oncotarget：抑制PC-PLC活性在原癌基因HER2相关的卵巢上皮癌中表现出治疗作用

2017-07-20

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

PDL-1和CTLA-4招募晚期尿路上皮癌患者

2017-06-18

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

SCI REP：ANLN有希望成为鉴定膀胱尿路上皮癌的预后生物标志物

2017-06-11

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Brit J Cancer：低密度脂蛋白胆固醇能够抵消酪氨酸激酶抑制剂对肾细胞上皮癌的抗肿瘤活性

2017-04-07

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Lancet Oncology：长春氟宁用于晚期尿路上皮癌的维持治疗

2017-04-06

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Cancer：尿液样本的下一代测序：卡介苗治疗非肌肉侵入尿路上皮癌患者的基因组分析新平台！

2017-03-29

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

NEJM：Pembrolizumab二线治疗尿路上皮癌优于化疗（KEYNOTE-045）

2017-03-21

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

NEJM：Pembrolizumab作为晚期尿路上皮癌二线治疗疗效如何？

2017-02-20

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

重磅！美国FDA批准百时美PD-1免疫疗法Opdivo治疗晚期尿路上皮癌（mUC）（CheckMate-275）

2017-02-08

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

lancet oncol：派姆单抗（pembrolizumab）在局部晚期或转移性尿路上皮癌患者中安全性和活性的1期临床研究(KEYNOTE-012)

2017-01-19

mashirong (审核中...)

前往app查看评论内容

#上皮癌#

Lancet：Atezolizumab可作为晚期尿路上皮癌顺铂的替代治疗

2016-12-09

科室
- - 订阅+
  - 更多科室
工具
服务